T1	Participants 105 121	type 2 diabetes:
T2	Participants 308 409	patients with type 2 diabetes (T2D) and inadequate glycaemic control on a sub-maximal metformin dose.
T3	Participants 475 536	metformin-tolerant patients with T2D on metformin monotherapy
T4	Participants 1200 1231	RESULTS A total of 286 patients
T5	Participants 2011 2112	CONCLUSIONS In metformin-tolerant patients with T2D (inadequately controlled on sub-maximal metformin
